Profound Hypothermia Best Avoided in Initial Reperfusion

This article originally appeared here.
Share this content:
Profound Hypothermia Best Avoided in Initial Reperfusion
Profound Hypothermia Best Avoided in Initial Reperfusion

THURSDAY, Jan. 21, 2016 (HealthDay News) -- For hearts donated after circulatory death (DCD), avoidance of profound hypothermia during initial reperfusion (IR) improves functional recovery, according to a study published online Jan. 18 in the American Journal of Transplantation.

C.W. White, from the University of Manitoba in Winnipeg, Canada, and colleagues examined the impact of IR temperature on the recovery of myocardial function during ex vivo heart perfusion (EVHP). They anesthetized 18 pigs and discontinued mechanical ventilation, resulting in cardiac arrest. The hearts were reperfused for three minutes at three different temperatures (5, 25, and 35 degrees Celsius) after a 15-minute stand-off period. Hearts then underwent normothermic EVHP for six hours, during which myocardial function was assessed.

The researchers found that the treatment groups differed significantly in IR coronary blood flow. Less myocardial injury and greater preservation of endothelial cell integrity were seen during subsequent EVHP in hearts initially reperfused at warmer temperatures. Recovery of myocardial function during EVHP was impaired with IR under profoundly hypothermic temperatures.

"We conclude that the avoidance of profound hypothermia during IR minimizes injury and improves the functional recovery of DCD hearts," the authors write.

Medical equipment was provided by medical device companies.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »